A

Autolus Therapeutics

Biotechnology · United Kingdom · 1,000 employees

126 Decision makers
+8 New (6 months)
1,000 Employees
$117M Revenue
2014 Founded

Organizational Chart of Autolus Therapeutics

Roles identified within Autolus Therapeutics's leadership team, from public professional data, updated 18 Oct 2026.

Department

Autolus Therapeutics's Full Organizational Chart

Loading…

Get their contacts on Zeliq →

Job title Department People Action

Decision makers at Autolus Therapeutics by function

General management

Finance

Tech & product

See all Autolus Therapeutics contacts on Zeliq

Decision makers at Autolus Therapeutics

126 identified 8 C-Level 14 VP 104 Directors +8 new (6 months)
See them on Zeliq →

Funding and news at Autolus Therapeutics

Funding

Last round Other · $75M
Total funding $1.2B (15 rounds)
Corporate Round N/A Jul 2014
Series A $45M Jan 2015
Series B $40M Mar 2016
Grant $745K Jan 2017
Series C $80M Sep 2017
Grant $2M Jan 2018
Post-IPO Equity $100M Apr 2019
Post-IPO Equity N/A Sep 2019
Grant $320K Jan 2020
Post-IPO Equity $100M Feb 2021
Post-IPO Equity $250M Nov 2021
Post-IPO Equity $122M Dec 2022
Post-IPO Equity $350M Feb 2024
Grant N/A Jan 2025
Post-IPO Debt $75M Jul 2026

Latest news at Autolus Therapeutics

  1. Appointment

    New Director, Msat appointed — Medical

  2. Appointment

    New Director, IT Infrastructure & Cybersecurity appointed — Engineering and technical

  3. Appointment

    New Associate Director, HR appointed — Human resources

  4. Appointment

    New Executive Director, Us Medical Affairs appointed — Medical

  5. Appointment

    New Executive Director, Global Clinical Development appointed — Medical

Get these new hires' email and phone →

Team Structure headcount by department

Operations
127
Research
110
Other
64
Technical
56
Medical
54
General Management
42
Project Management
32
HR
23

How to prospect Autolus Therapeutics's departments

Operations

The company's largest department, with 127 people. Operations leaders live in the concrete: a pilot scoped on one process will convince more than a demo.

Research

With 110 people, this is the organisation's second pillar. Researchers respond to substance: reference publications, benchmarks or datasets relevant to their field.

Other

This department counts 64 people. Hard to read from the outside: use a first exchange to map who does what before pushing an offer.

Technical

56 people work in this department. Technical teams verify claims: public docs, a sandbox or a free tier will do the selling for you.

Medical

A team of 54 people. Regulatory constraints and protocols shape everything here: show you understand their compliance context before pitching.

General Management

This department counts 42 people. A good executive approach often starts lower in the organisation: build an internal champion before going top-down.

Try the Zeliq email finder demo →

FAQ Autolus Therapeutics

Who runs Autolus Therapeutics?

The highest-ranking leadership role identified at Autolus Therapeutics is “CFO”, based on public data updated 18 Oct 2026.

How many decision makers does Autolus Therapeutics have?

126 decision makers identified, including 8 at executive level.

How do I contact a decision maker at Autolus Therapeutics?

Verified emails and phone numbers are available in Zeliq, with free credits at sign-up.

Companies similar to Autolus Therapeutics

More companies to explore

Biotechnology · United Kingdom

All Biotechnology companies in United Kingdom →

About Autolus Therapeutics

Autolus Therapeutics operates in the Biotechnology industry, operating from United Kingdom. The company was founded in 2014 and employs approximately 1,000 people. As part of the broader Hospitals and Health Care sector, Autolus Therapeutics operates specifically in the Biotechnology segment. Autolus Therapeutics is a B2B company, primarily serving business clients and professional organisations. The company has secured 15 rounds of funding totalling $1.2B. Annual revenue is estimated at around $117M. Use this page to review Autolus Therapeutics's industry, headcount, location and hiring signals, and to reach verified B2B contacts before your next outreach.

Activity & Market

Autolus Therapeutics is positioned on the Biotechnology segment, within the Hospitals and Health Care sector. As a B2B company, Autolus Therapeutics primarily serves business clients and professional organisations. The company is categorised as “Public company”.